Named as a key player in 66 of our reports, across 33 regions and countries.
Our reports that name Ascensia Diabetes Care as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Ascensia Diabetes Care (number of shared markets).
Dexcom, Inc.2 shared markets
Insulet Corporation2 shared markets
LifeScan, Inc.2 shared markets
Medtronic2 shared markets
Roche Diabetes Care2 shared markets
AgaMatrix Holdings LLC1 shared market
Bionime Corporation1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
0 active studies led by Ascensia Diabetes Care, of 43 in all
Source: ClinicalTrials.gov, Studies with Ascensia Diabetes Care (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
13 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Includes Ascensia Diabetes Care U.S., Inc.. Retrieved 13 Nov 2026.
Studies Ascensia Diabetes Care leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Ascensia Diabetes Care or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets Ascensia Diabetes Care is in.
Stories on the topics Ascensia Diabetes Care works in.
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read